HTX 0.00% 0.1¢ healthlinx limited

No I'm actually not Prof Ian Frazer but thought the nic was in...

  1. 118 Posts.
    No I'm actually not Prof Ian Frazer but thought the nic was in good jest...I'm interested in a number areas of oncology diagnosis and treatment

    The ovarian cancer diagnosis space whilst highly interesting is a very difficult area to say the least. A good example is how long it took Digene to get traction with cervical cancer screening. By its nature Ovarian cancer is a far more difficult space and scientific literature is probably 10-15 years behind cervical cancer in acceptance of screening.

    As a screening tool the 2 key data aspects are sensitivity and negative predictive value (NPV)...forget the rest...I dont understand why HTX keeps on harping on about "diagnostic efficiency"
 
watchlist Created with Sketch. Add HTX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.